Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06797219 · ClinicalTrials.gov registry record · NA
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
A NA study of Hydrocephalus and Intraventricular Hemorrhage of Prematurity, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT06797219: Recruiting NA study of Hydrocephalus and Intraventricular Hemorrhage of Prematurity, sponsored by Rutgers, The State University of New Jersey.
NCT06797219 is a NA study of Hydrocephalus and Intraventricular Hemorrhage of Prematurity that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 24 participants, below the 132-participant average among 17 other Hydrocephalus trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06797219, a NA study of Hydrocephalus and Intraventricular Hemorrhage of Prematurity, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers\' experience with the study intervention. A complete list of objectives and aims are listed under "Objectives". This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.
Primary Outcome
Measure rate at which neonate intraventricular hemorrhage is resorbed via serial head ultrasounds
Conditions Studied
Interventions
- DEVICE Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity
Study Locations (2)
New Jersey
- Rutgers - New Jersey Medical School / University Hospital - Newark
- Newark Beth Israel Medical Center - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-02-25 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT06797219 shows while recruiting
NCT06797219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 132-participant average among 17 other Hydrocephalus trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity is the first listed.
NCT06797219 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06797219 about?
NCT06797219 is a clinical study titled "Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4". The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by pare...
What is the current status of trial NCT06797219?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-02-25. Estimated completion is 2028-07-31.
What conditions does trial NCT06797219 study?
This clinical trial studies the following conditions: Hydrocephalus, Intraventricular Hemorrhage of Prematurity.
What interventions are being tested in trial NCT06797219?
The interventions under investigation include: Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity (DEVICE).
Who is sponsoring clinical trial NCT06797219?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06797219 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06797219's enrollment target sits among peer trials
24 17th of 17 the lowest of 17 other Hydrocephalus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hydrocephalus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
RECRUITING · NA
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
RECRUITING · NA
-
Flow Detection in Open and Closed Shunt Valve Periods
RECRUITING · NA
-
Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
RECRUITING · NA
-
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
RECRUITING · NA
-
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI